COVID-19 and immunomodulation treatment for women with reproductive failures

COVID-19 pandemic is affecting various areas of health care, including human reproduction. Many women with reproductive failures, during the peri-implantation period and pregnancy, are on the immunotherapy using immune modulators and immunosuppressant due to underlying autoimmune diseases, cellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak-Kim, Joanne, Ota, Kuniaki, Sung, Nayoung, Huang, Changsheng, Alsubki, Lujain, Lee, Sungki, Han, Jae Won, Han, Aera, Yang, Xiuhua, Saab, Wael, Derbala, Youssef, Wang, Wen-Juan, He, Qiaohua, Liao, Aihua, Takahashi, Toshifumi, Cavalcante, Marcelo Borges, Barini, Ricardo, Bao, Shihua, Fukui, Atsushi, Lédée, Nathalie, Coulam, Carolyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291967/
https://www.ncbi.nlm.nih.gov/pubmed/32603991
http://dx.doi.org/10.1016/j.jri.2020.103168
_version_ 1783546007055761408
author Kwak-Kim, Joanne
Ota, Kuniaki
Sung, Nayoung
Huang, Changsheng
Alsubki, Lujain
Lee, Sungki
Han, Jae Won
Han, Aera
Yang, Xiuhua
Saab, Wael
Derbala, Youssef
Wang, Wen-Juan
He, Qiaohua
Liao, Aihua
Takahashi, Toshifumi
Cavalcante, Marcelo Borges
Barini, Ricardo
Bao, Shihua
Fukui, Atsushi
Lédée, Nathalie
Coulam, Carolyn
author_facet Kwak-Kim, Joanne
Ota, Kuniaki
Sung, Nayoung
Huang, Changsheng
Alsubki, Lujain
Lee, Sungki
Han, Jae Won
Han, Aera
Yang, Xiuhua
Saab, Wael
Derbala, Youssef
Wang, Wen-Juan
He, Qiaohua
Liao, Aihua
Takahashi, Toshifumi
Cavalcante, Marcelo Borges
Barini, Ricardo
Bao, Shihua
Fukui, Atsushi
Lédée, Nathalie
Coulam, Carolyn
author_sort Kwak-Kim, Joanne
collection PubMed
description COVID-19 pandemic is affecting various areas of health care, including human reproduction. Many women with reproductive failures, during the peri-implantation period and pregnancy, are on the immunotherapy using immune modulators and immunosuppressant due to underlying autoimmune diseases, cellular immune dysfunction, and rheumatic conditions. Many questions have been raised for women with immunotherapy during the COVID-19 pandemic, including infection susceptibility, how to manage women with an increased risk of and active COVID-19 infection. SARS-CoV-2 is a novel virus, and not enough information exists. Yet, we aim to review the data from previous coronavirus outbreaks and current COVID-19 and provide interim guidelines for immunotherapy in women with reproductive failures.
format Online
Article
Text
id pubmed-7291967
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-72919672020-06-12 COVID-19 and immunomodulation treatment for women with reproductive failures Kwak-Kim, Joanne Ota, Kuniaki Sung, Nayoung Huang, Changsheng Alsubki, Lujain Lee, Sungki Han, Jae Won Han, Aera Yang, Xiuhua Saab, Wael Derbala, Youssef Wang, Wen-Juan He, Qiaohua Liao, Aihua Takahashi, Toshifumi Cavalcante, Marcelo Borges Barini, Ricardo Bao, Shihua Fukui, Atsushi Lédée, Nathalie Coulam, Carolyn J Reprod Immunol Review Article COVID-19 pandemic is affecting various areas of health care, including human reproduction. Many women with reproductive failures, during the peri-implantation period and pregnancy, are on the immunotherapy using immune modulators and immunosuppressant due to underlying autoimmune diseases, cellular immune dysfunction, and rheumatic conditions. Many questions have been raised for women with immunotherapy during the COVID-19 pandemic, including infection susceptibility, how to manage women with an increased risk of and active COVID-19 infection. SARS-CoV-2 is a novel virus, and not enough information exists. Yet, we aim to review the data from previous coronavirus outbreaks and current COVID-19 and provide interim guidelines for immunotherapy in women with reproductive failures. Elsevier B.V. 2020-09 2020-06-12 /pmc/articles/PMC7291967/ /pubmed/32603991 http://dx.doi.org/10.1016/j.jri.2020.103168 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Kwak-Kim, Joanne
Ota, Kuniaki
Sung, Nayoung
Huang, Changsheng
Alsubki, Lujain
Lee, Sungki
Han, Jae Won
Han, Aera
Yang, Xiuhua
Saab, Wael
Derbala, Youssef
Wang, Wen-Juan
He, Qiaohua
Liao, Aihua
Takahashi, Toshifumi
Cavalcante, Marcelo Borges
Barini, Ricardo
Bao, Shihua
Fukui, Atsushi
Lédée, Nathalie
Coulam, Carolyn
COVID-19 and immunomodulation treatment for women with reproductive failures
title COVID-19 and immunomodulation treatment for women with reproductive failures
title_full COVID-19 and immunomodulation treatment for women with reproductive failures
title_fullStr COVID-19 and immunomodulation treatment for women with reproductive failures
title_full_unstemmed COVID-19 and immunomodulation treatment for women with reproductive failures
title_short COVID-19 and immunomodulation treatment for women with reproductive failures
title_sort covid-19 and immunomodulation treatment for women with reproductive failures
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291967/
https://www.ncbi.nlm.nih.gov/pubmed/32603991
http://dx.doi.org/10.1016/j.jri.2020.103168
work_keys_str_mv AT kwakkimjoanne covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT otakuniaki covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT sungnayoung covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT huangchangsheng covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT alsubkilujain covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT leesungki covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT hanjaewon covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT hanaera covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT yangxiuhua covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT saabwael covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT derbalayoussef covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT wangwenjuan covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT heqiaohua covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT liaoaihua covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT takahashitoshifumi covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT cavalcantemarceloborges covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT bariniricardo covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT baoshihua covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT fukuiatsushi covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT ledeenathalie covid19andimmunomodulationtreatmentforwomenwithreproductivefailures
AT coulamcarolyn covid19andimmunomodulationtreatmentforwomenwithreproductivefailures

Ejemplares similares